← American Academy of Pediatrics (AAP)
FDANonrulemakingFDA-2020-N-1046

Use of Codeine-Containing Analgesics in Children Under 12 Years of Age Subsequent to CYP2D6 Genetic Testing; Establishment of a Public Docket; Request for Comments

RIN
—
Last modified
Aug 31, 2020
Comment window
closed 2160d ago
American Academy of Pediatrics (AAP) filings
1

Activity

American Academy of Pediatrics (AAP) filed 1 comment on this docket between Aug 28, 2020 and Aug 28, 2020. 3 other organizations filed here. The comment window closed 2160d ago.

What American Academy of Pediatrics (AAP) filed (1)

Aug 28, 2020· Comment from American Academy of Pediatrics· FDA-2020-N-1046-0004

Filed on regulations.gov — full text not in the inline record.

View on regulations.gov →

Abstract

No abstract recorded.

View on regulations.gov →

Co-filers (3)

See everyone who commented →
Use of Codeine-Containing Analgesics in Children Under 12 Years of Age Subsequent to CYP2D6 Genetic Testing; Establishment of a Public Docket; Request for Comments (FDA) — American Academy of Pediatrics (AAP) | OpenPolis